Virtual Medicinal Product (VMP)
-
Dexrazoxane 500mg powder for solution for infusion vials
Name Details
Current Name
Dexrazoxane 500mg powder for solution for infusion vials
|
Start Date
14-01-2009
|
End Date
|
Previous Name
Dexrazoxane 500mg powder for solution for injection vials
|
Start Date
05-09-2007
|
End Date
13-01-2009
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- vial
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intravenous
- Form
- Powder for solution for infusion
- Ontology Form/Route
- solutioninfusion.intravenous
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
V03AF02
BNF |
Current BNF
08010000
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
08010000
|
Start Date
08-05-2008
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
11937411000001109 |
05-09-2007 |
|
VMP Ingredients
VMP ingredients table
Dexrazoxane |
Based on Ingredient Substance |
|
500 mg |
|
Name
Dexrazoxane
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
500.0
Strength and UOM (Dmr)
Parent Products
-
VTM
Dexrazoxane
-
VMP
(Current) Dexrazoxane 500mg powder for solutio...
Virtual Medicinal Product Pack (VMPP) Information